rs55792866

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000719.7(CACNA1C):​c.372-15G>A variant causes a intron change. The variant allele was found at a frequency of 0.0251 in 1,264,380 control chromosomes in the GnomAD database, including 539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 88 hom., cov: 33)
Exomes 𝑓: 0.025 ( 451 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.47
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 12-2120310-G-A is Benign according to our data. Variant chr12-2120310-G-A is described in ClinVar as [Benign]. Clinvar id is 35768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-2120310-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0294 (4469/152234) while in subpopulation AFR AF= 0.0487 (2024/41538). AF 95% confidence interval is 0.047. There are 88 homozygotes in gnomad4. There are 2154 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4469 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.372-15G>A intron_variant Intron 2 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.372-15G>A intron_variant Intron 2 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.372-15G>A intron_variant Intron 2 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.372-15G>A intron_variant Intron 2 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.462-15G>A intron_variant Intron 2 of 49 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.372-15G>A intron_variant Intron 2 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.372-15G>A intron_variant Intron 2 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.462-15G>A intron_variant Intron 2 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.372-15G>A intron_variant Intron 2 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.372-15G>A intron_variant Intron 2 of 47 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.372-15G>A intron_variant Intron 2 of 47 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.462-15G>A intron_variant Intron 2 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.462-15G>A intron_variant Intron 2 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.462-15G>A intron_variant Intron 2 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.462-15G>A intron_variant Intron 2 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.372-15G>A intron_variant Intron 2 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.372-15G>A intron_variant Intron 2 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.372-15G>A intron_variant Intron 2 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.372-15G>A intron_variant Intron 2 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.372-15G>A intron_variant Intron 2 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.372-15G>A intron_variant Intron 2 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.372-15G>A intron_variant Intron 2 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.372-15G>A intron_variant Intron 2 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.372-15G>A intron_variant Intron 2 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.372-15G>A intron_variant Intron 2 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.372-15G>A intron_variant Intron 2 of 45 ENSP00000507309.1 Q13936-19
CACNA1CENST00000682152.1 linkc.321-15G>A intron_variant Intron 1 of 5 ENSP00000506759.1 A0A804HHT8
CACNA1CENST00000480911.6 linkn.372-15G>A intron_variant Intron 2 of 26 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0293
AC:
4461
AN:
152116
Hom.:
87
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0487
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.0377
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0258
Gnomad OTH
AF:
0.0235
GnomAD3 exomes
AF:
0.0234
AC:
5833
AN:
248948
Hom.:
99
AF XY:
0.0245
AC XY:
3306
AN XY:
135010
show subpopulations
Gnomad AFR exome
AF:
0.0463
Gnomad AMR exome
AF:
0.0114
Gnomad ASJ exome
AF:
0.0225
Gnomad EAS exome
AF:
0.0000555
Gnomad SAS exome
AF:
0.0371
Gnomad FIN exome
AF:
0.0122
Gnomad NFE exome
AF:
0.0265
Gnomad OTH exome
AF:
0.0184
GnomAD4 exome
AF:
0.0245
AC:
27248
AN:
1112146
Hom.:
451
Cov.:
16
AF XY:
0.0254
AC XY:
14500
AN XY:
570822
show subpopulations
Gnomad4 AFR exome
AF:
0.0484
Gnomad4 AMR exome
AF:
0.0118
Gnomad4 ASJ exome
AF:
0.0227
Gnomad4 EAS exome
AF:
0.000184
Gnomad4 SAS exome
AF:
0.0393
Gnomad4 FIN exome
AF:
0.0115
Gnomad4 NFE exome
AF:
0.0250
Gnomad4 OTH exome
AF:
0.0235
GnomAD4 genome
AF:
0.0294
AC:
4469
AN:
152234
Hom.:
88
Cov.:
33
AF XY:
0.0289
AC XY:
2154
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.0487
Gnomad4 AMR
AF:
0.0156
Gnomad4 ASJ
AF:
0.0179
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0375
Gnomad4 FIN
AF:
0.0135
Gnomad4 NFE
AF:
0.0258
Gnomad4 OTH
AF:
0.0251
Alfa
AF:
0.0255
Hom.:
16
Bravo
AF:
0.0294
Asia WGS
AF:
0.0170
AC:
60
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 11, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: CACNA1C c.372-15G>A alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.023 in 248948 control chromosomes in the gnomAD database, including 99 homozygotes. The observed variant frequency is approximately 2343-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.372-15G>A in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Benign:1
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Long QT syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
16
DANN
Benign
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55792866; hg19: chr12-2229476; API